back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-07 20:42 Tx date 2024-09-30 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,749
+19,583 vol $0.60 each |
71,293 | |
| Filed 2024-07-08 17:28 Tx date 2024-06-26 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+32,979 vol |
98,340 | |
| Filed 2024-07-08 17:27 Tx date 2024-06-26 |
$NPTH
NeuPath Health Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
57 - Exercise of rights
|
$-6,430.905
-32,979 vol $0.195 each |
0 | |
| Filed 2023-06-25 23:21 Tx date 2023-06-20 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
$11,750
+18,077 vol $0.65 each |
51,710 | |
| Filed 2023-06-16 12:29 Tx date 2023-06-15 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
56 - Grant of rights
|
+32,979 vol |
32,979 | |
| Filed 2023-06-16 12:26 Tx date 2023-06-15 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,829
+98,935 vol $0.16 each |
159,351 | |
| Filed 2023-06-09 13:05 Tx date 2023-06-07 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,083
+13,889 vol $0.15 each |
65,361 | |
| Filed 2023-06-09 13:04 Tx date 2023-06-07 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
57 - Exercise of rights
|
-13,889 vol |
0 | |
| Filed 2023-05-03 18:10 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
+$20,000 vol |
$20,000 | |
| Filed 2023-05-03 17:09 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $0.09 each |
$20 | |
| Filed 2023-05-03 17:09 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20 vol $0.09 each |
||
| Filed 2023-05-03 16:27 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20,000 vol $0.09 each |
$20,000 | |
| Filed 2023-05-03 16:27 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20,000 vol $0.09 each |
||
| Filed 2023-05-03 16:27 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
11 - Acquisition or disposition carried out privately
|
$
+$20,000 vol $0.09 each |
||
| Filed 2023-05-03 16:26 Tx date 2020-06-25 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-03 16:25 Tx date 2023-05-02 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,999
+22,222 vol $0.09 each |
51,472 | |
| Filed 2022-06-29 15:45 Tx date 2022-05-31 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+41,666 vol |
60,416 | |
| Filed 2022-06-29 15:44 Tx date 2022-05-31 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
56 - Grant of rights
|
$6,250
+13,889 vol $0.45 each |
13,889 | |
| Filed 2022-06-29 15:38 Tx date 2022-05-31 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
56 - Grant of rights
|
$18,749
+41,666 vol $0.45 each |
||
| Filed 2022-06-29 15:37 Tx date 2022-05-31 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+13,889 vol |
||
| Filed 2022-05-19 21:59 Tx date 2022-05-18 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+12,113 vol |
19,793 | |
| Filed 2022-05-17 12:47 Tx date 2022-05-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+16,096 vol |
33,633 | |
| Filed 2022-04-03 21:17 Tx date 2022-03-29 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-44,368 vol |
691,158 | |
| Filed 2021-12-28 11:26 Tx date 2021-12-22 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+17,537 vol |
17,537 | |
| Filed 2021-12-28 11:22 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-22 11:27 Tx date 2021-12-21 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-44,368 vol |
85,845 | |
| Filed 2021-12-17 17:08 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,170
+3,500 vol $0.62 each |
11,900 | |
| Filed 2021-12-17 17:07 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,210
+3,400 vol $0.65 each |
8,400 | |
| Filed 2021-12-17 17:07 Tx date 2021-12-15 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,400
+5,000 vol $0.68 each |
5,000 | |
| Filed 2021-12-17 17:06 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-16 09:42 Tx date 2021-09-09 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,250 vol |
29,250 | |
| Filed 2021-09-16 09:39 Tx date 2021-09-09 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
57 - Exercise of rights
|
-6,250 vol |
0 | |
| Filed 2021-09-01 11:31 Tx date 2021-08-31 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,490
+23,000 vol $0.63 each |
23,000 | |
| Filed 2021-09-01 11:30 Tx date 2020-06-25 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-08-26 15:52 Tx date 2021-08-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-10,623.7472
-8,812 vol $1.21 each |
735,526 | |
| Filed 2021-08-17 08:27 Tx date 2021-08-17 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-8,812 vol |
130,213 | |
| Filed 2021-05-21 12:05 Tx date 2021-05-20 |
$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
56 - Grant of rights
|
+7,680 vol |
7,680 | |
| Filed 2020-09-04 16:07 Tx date 2020-09-01 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$16,312
+18,750 vol $0.87 each |
18,750 | |
| Filed 2020-09-04 16:04 Tx date 2020-06-25 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 16:04 Tx date 2020-09-01 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
56 - Grant of rights
|
$5,437
+6,250 vol $0.87 each |
6,250 | |
| Filed 2020-09-04 16:00 Tx date 2020-06-25 |
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-24 15:17 Tx date 2020-08-17 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+10,000 vol $0.60 each |
744,338 | |
| Filed 2020-06-17 16:07 Tx date 2020-06-17 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
734,338 | |
| Filed 2020-06-16 16:09 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
139,025 | |
| Filed 2020-05-14 14:01 Tx date 2020-05-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
155,633 | |
| Filed 2019-08-20 09:57 Tx date 2019-08-19 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
148,633 | |
| Filed 2019-05-25 14:46 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
750,946 | |
| Filed 2019-05-24 12:04 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
||
| Filed 2019-05-24 12:04 Tx date 2019-05-21 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,800
+10,000 vol $0.78 each |
750,946 | |
| Filed 2019-01-03 Tx date 2019-01-03 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,195 vol |
0 | |
| Filed 2019-01-03 Tx date 2019-01-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,195 vol |
0 | |
| Filed 2018-05-30 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-40,999.74
-77,358 vol $0.53 each |
0 | |
| Filed 2018-05-30 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+77,358 vol |
77,358 | |
| Filed 2018-05-30 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-05-30 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
$20,499
+38,679 vol $0.53 each |
124,879 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
740,946 | |
| Filed 2018-03-29 Tx date 2017-11-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
134,633 | |
| Filed 2018-03-29 Tx date 2017-11-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
730,946 | |
| Filed 2018-03-29 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
| Filed 2018-03-29 Tx date 2017-12-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
||
| Filed 2018-03-28 Tx date 2018-03-28 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+7,000 vol |
141,633 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
57 - Exercise of rights
|
$-500,334.84
-944,028 vol $0.53 each |
0 | |
| Filed 2018-03-16 Tx date 2018-02-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
56 - Grant of rights
|
+514,028 vol |
514,028 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$5,499
+10,377 vol $0.53 each |
119,577 | |
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$20,561
+38,795 vol $0.53 each |
38,795 | |
| Filed 2018-03-16 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal Joint Account (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-03-16 Tx date 2018-03-13 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$224,106
+422,842 vol $0.53 each |
645,999 | |
| Filed 2018-03-09 Tx date 2018-03-08 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
10 - Acquisition or disposition in the public market
|
$4,300
+430,000 vol $0.01 each |
430,000 | |
| Filed 2018-03-09 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-82,080.80
-22,184 vol $3.70 each |
17,195 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,193 vol |
39,379 | |
| Filed 2018-01-03 Tx date 2018-01-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-39,377 vol |
17,195 | |
| Filed 2017-12-08 Tx date 2017-12-06 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
730,946 | |
| Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,996
+86,200 vol $0.58 each |
109,200 | |
| Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$49,996
+86,200 vol $0.58 each |
86,200 | |
| Filed 2017-12-07 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Spousal TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-12-07 Tx date 2017-12-05 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60,087
+103,600 vol $0.58 each |
116,227 | |
| Filed 2017-12-06 Tx date 2017-12-06 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-53,846 vol |
134,633 | |
| Filed 2017-07-11 Tx date 2017-07-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,100
+5,000 vol $0.62 each |
23,000 | |
| Filed 2017-07-11 Tx date 2017-07-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$620.00
+1,000 vol $0.62 each |
18,000 | |
| Filed 2017-07-11 Tx date 2017-07-07 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,640
+4,000 vol $0.66 each |
17,000 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$750.00
+1,000 vol $0.75 each |
13,000 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,550
+7,000 vol $0.65 each |
12,000 | |
| Filed 2017-07-04 Tx date 2017-06-29 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+5,000 vol $0.65 each |
5,000 | |
| Filed 2017-07-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-06-28 Tx date 2017-06-28 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
784,792 | |
| Filed 2017-03-08 Tx date 2017-03-07 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,687 vol |
188,479 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-462,328.20
-81,828 vol $5.65 each |
56,572 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
38 - Redemption, retraction, cancellation, repurchase
|
-17,193 vol |
56,572 | |
| Filed 2017-01-04 Tx date 2017-01-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-76,269.30
-64,635 vol $1.18 each |
73,765 | |
| Filed 2016-05-18 Tx date 2016-05-16 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+302,000 vol |
484,792 | |
| Filed 2016-03-14 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+169,807 vol |
169,807 | |
| Filed 2016-03-14 Tx date 2013-10-30 |
$NRI
Nuvo Research Inc. (formerly Dimethaid Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Rights Share Appreciation Rights Plan (SAR)
56 - Grant of rights
|
+169,447 vol |
||
| Filed 2016-03-14 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
138,400 | ||
| Filed 2016-03-14 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
|
-43,882 vol |
0 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
|
-57,072 vol |
43,882 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+57,072 vol |
223,157 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
00 - Opening Balance-Initial SEDI Report
|
138,040 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
182,792 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,627 | ||
| Filed 2016-03-04 Tx date 2016-03-01 |
$CTX
Crescita Therapeutics Inc. |
Chicoine, Daniel
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
223,157 | ||
| Filed 2016-02-29 Tx date 2016-02-29 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
97 - Other
|
-7 vol |
182,792 | |
| Filed 2016-01-06 Tx date 2016-01-01 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Share Appreciation Rights Plan (SAR)
59 - Exercise for cash
|
$-426,323.88
-81,828 vol $5.21 each |
138,040 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-10,929 vol |
0 | |
| Filed 2015-12-11 Tx date 2015-12-09 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$32,787
+10,929 vol $3.00 each |
166,085 | |
| Filed 2015-09-24 Tx date 2015-09-21 |
$NRI
Nuvo Research Inc. |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-399,997
-30,769 vol $13.00 each |
182,799 |